Search
GSK plc
GSKAdd to Watchlist
50.745USD
-0.015-0.03%
Close 07-23 16:00（ET）Quotes delayed by 15 min
102.88BMarket Cap
13.08P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-23The current earnings forecast score of GSK plc is 6.89, ranking 121 out of 155 in the Pharmaceuticals industry. The average price target is 45.30, with a high of 56.23 and a low of 34.26.
Analyst Rating
Based on
10
analysts
Buy
Current Rating
54.011
Target Price
+6.36%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
GSK plc
GSK
10
Biogen Inc
BIIB
38
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is GSK plc's expected revenue for the next quarter?
GSK plc's expected revenue is 10.98B.
What is GSK plc's price target?
Analysts forecast that GSK plc's price target is USD 45.30, with the highest forecast at USD 56.23 and the lowest forecast at USD 34.26.
How have GSK plcGSK's recent earnings per share performed?
The market expectation was USD 1.16, while GSK plcGSK's earnings per share (EPS) for the previous quarter was USD 0.42. EPS for the next quarter is expected at USD 1.24.
What is the analyst rating for GSK plc?
Based on the ratings of GSK plc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.